Table 1 Patient Demographics for group 1, 2, and 3
|  | N reported | Group 1 (N = 12) | Group 2 (N = 37) | Group 3 (N = 26) | Combined | P-value |
|---|---|---|---|---|---|---|
Age | 74 | 63.0 (58.2–68.2) | 64.0 (58.0–68.0) | 63.0 (59.0–69.0) | 63.0 (58.2–69.0) | 0.921 |
Gender | 75 | Â | Â | Â | Â | 0.939 |
Female | Â | 3 (25%) | 10 (27%) | 6 (23%) | 19 (25%) | Â |
Male | Â | 9 (75%) | 27 (73%) | 20 (77%) | 56 (75%) | Â |
Race | 75 | Â | Â | Â | Â | 0.735 |
American Indian /Alaska | Â | 0 (0%) | 1 (3%) | 0 (0%) | 1 (1%) | Â |
Asian | Â | 0 (0%) | 2 (5%) | 1 (4%) | 3 (4%) | Â |
Black | Â | 0 (0%) | 4 (11%) | 4 (15%) | 8 (11%) | Â |
Native Hawaiian | Â | 0 (0%) | 1 (3%) | 0 (0%) | 1 (1%) | Â |
Other | Â | 0 (0%) | 1 (3%) | 1 (4%) | 2 (3%) | Â |
Unknown | Â | 2 (17%) | 1 (3%) | 1 (4%) | 4 (5%) | Â |
White | Â | 10 (83%) | 27 (73%) | 19 (73%) | 56 (75%) | Â |
Ethnicity | 75 | Â | Â | Â | Â | 0.499 |
Hispanic or Latino | Â | 1 (8%) | 1 (3%) | 2 (8%) | 4 (5%) | Â |
Non-Hispanic | Â | 9 (75%) | 34 (92%) | 22 (85%) | 65 (87%) | Â |
Unknown | Â | 2 (17%) | 2 (5%) | 1 (4%) | 5 (7%) | Â |
Other | Â | 0 (0%) | 0 (0%) | 1 (4%) | 1 (1%) | Â |
Causes of Cirrhosis | ||||||
Alcohol | 75 | Â | Â | Â | Â | 0.094 |
Yes | Â | 2 (17%) | 11 (30%) | 2 (8%) | 15 (20%) | Â |
No | Â | 10 (83%) | 26 (70%) | 24 (92%) | 60 (80%) | Â |
Hepatitis B | 75 | Â | Â | Â | Â | 0.508 |
Yes | Â | 0 (0%) | 3 (8%) | 1 (4%) | 4 (5%) | Â |
No | Â | 12 (100%) | 34 (92%) | 25 (96%) | 71 (95%) | Â |
Hepatitis C | 75 | Â | Â | Â | Â | 0.869 |
Yes | Â | 5 (42%) | 15 (41%) | 9 (35%) | 29 (39%) | Â |
No | Â | 7 (58%) | 22 (59%) | 17 (65%) | 46 (61%) | Â |
NASH | 75 | Â | Â | Â | Â | 0.011 |
Yes | Â | 4 (33%) | 1 (3%) | 3 (12%) | 8 (11%) | Â |
No | Â | 8 (67%) | 36 (97%) | 23 (88%) | 67 (89%) | Â |
Other | 75 | Â | Â | Â | Â | 0.908 |
Yes | Â | 1 (8%) | 2 (5%) | 2 (8%) | 5 (7%) | Â |
No | Â | 11 (92%) | 36 (97%) | 23 (88%) | 67 (89%) | Â |
Bilirubin | 74 | 0.800 (0.675–0.925) | 1.05 (0.600–1.625) | 0.700 (0.500–0.900) | 0.800 (0.600–1.300) | 0.023 |
Albumin | 74 | 3.60 (3.18–3.92) | 3.50 (3.20–3.68) | 3.35 (3.08–3.60) | 3.50 (3.10–3.70) | 0.324 |
Ascites | 75 | Â | Â | Â | Â | 0.014 |
Yes | Â | 2 (17%) | 16 (43%) | 3 (12%) | 21 (28%) | Â |
No | Â | 10 (83%) | 21 (57%) | 23 (88%) | 54 (72%) | Â |
Hepatic Encephalopathy | 75 | Â | Â | Â | Â | 0.333 |
Yes | Â | 1 (8%) | 1 (3%) | 0 (0%) | 2 (3%) | Â |
No | Â | 11 (92%) | 36 (97%) | 26 (100%) | 73 (97%) | Â |
MELD | 70 | 8.0 (7.0–9.5) | 10.0 (8.0–12.0) | 7.0 (6.0–9.0) | 9.0 (7.0–11.0) |  < 0.001 |
Child Pugh Class | 70 |  |  |  |  |  < 0.001 |
Class A | Â | 12 (100%) | 14 (39%) | 18 (82%) | 44 (63%) | Â |
Class B/C | Â | 0 (0%) | 22 (61%) | 4 (18%) | 26 (37%) | Â |